logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11311510 B1

PDFFull Text
Date of Patent:
Apr. 26, 2022

Filed:

Feb. 13, 2020

Esters for treatment of ocular inflammatory conditions

Applicant:

Johnson & Johnson Vision Care, Inc., Jacksonville, FL (US);

Inventor:

Annabelle Gallois-Bernos, Jacksonville, FL (US);

Assignee:

Johnson & Johnson Vision Care, Inc., Jacksonville, FL (US);

Attorney:
Primary Examiner:

Craig D Ricci

Int. Cl.
CPC ...
A61K 31/232 (2006.01); A61K 31/557 (2006.01); A61K 31/215 (2006.01); A61K 31/5575 (2006.01); A61K 31/661 (2006.01); A61K 9/00 (2006.01); A61K 31/16 (2006.01); A61K 31/201 (2006.01); A61K 31/202 (2006.01); A61K 31/203 (2006.01); A61K 31/683 (2006.01); A61K 9/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/232 (2013.01); A61K 9/0048 (2013.01); A61K 31/16 (2013.01); A61K 31/201 (2013.01); A61K 31/202 (2013.01); A61K 31/203 (2013.01); A61K 31/215 (2013.01); A61K 31/557 (2013.01); A61K 31/5575 (2013.01); A61K 31/661 (2013.01); A61K 31/683 (2013.01); A61K 9/08 (2013.01);
Abstract

The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a polyol wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. Anti-inflammatory lipid mediators can be selected from the group consisting of polyunsaturated fatty acids (e.g., omega-three and omega-six fatty acids), resolvins or a metabolically stable analog, protectins or a metabolically stable analog, lipoxins or a metabolically stable analog, prostaglandins or a metabolically stable analog, retinoic acids, endocannabinoids, metabolites thereof, and mixtures thereof. This composition can be topically delivered to the ocular surface via a preparation, solution, gel, ointment, and/or strip and/or a contact lens.

Find Patent Forward Citations

Gallois-Bernos, Annabelle. (2022). Esters for treatment of ocular inflammatory conditions (U.S. Patent No. 11311510). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11311510

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…